| 英文名称 |
中文名称 |
CAS号 |
操作 |
| GW-1100 |
GW 1100 |
306974-70-9 |
详细
|
| PH-064 |
892546-37-1 |
892546-37-1 |
详细
|
| ML216 |
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲 |
1430213-30-1 |
详细
|
| Entasobulin |
501921-61-5 |
501921-61-5 |
详细
|
| Boc-Dap-NE |
BOC-DAP-NE |
160800-65-7 |
详细
|
| Roblitinib (FGF401) |
8-二氮杂萘-1(2H)-甲酰胺 |
1708971-55-4 |
详细
|
| Orelabrutinib |
奥布替尼 |
1655504-04-3 |
详细
|
| ML-162 |
ML162 |
1035072-16-2 |
详细
|
| LEM-14 |
化合物 T9006 |
1814881-70-3 |
详细
|
| MSBN |
MSBN |
135980-66-4 |
详细
|
| DL5H3 |
1-Piperidinepropanamide, N-[1,2,3,9-tetrahydro-9-oxo-3-(phenylmethylene)pyrrolo[2,1-b]quinazolin-6-yl]- |
90263-34-6 |
详细
|
| Nicomol |
尼可莫尔 |
27959-26-8 |
详细
|
| Dronedarone |
决奈达隆 |
141626-36-0 |
详细
|
| GRA Ex-25 |
N-[4-[[[反式-4-(1,1-二甲基乙基)环己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]苄基]-B-丙氨酸 |
307983-31-9 |
详细
|
| CCT241736 |
CS-2683 |
1402709-93-6 |
详细
|
| TIC10 (ONC201) |
ONC201 |
1616632-77-9 |
详细
|
| BI-847325 |
BI-847325 |
1207293-36-4 |
详细
|
| PF-05221304 |
化合物PF-05221304 |
1370448-25-1 |
详细
|
| SYP-5 |
1384268-04-5 |
1384268-04-5 |
详细
|
| Batefenterol |
BATEFENTEROL |
743461-65-6 |
详细
|
| FB23 |
FB23 |
2243736-35-6 |
详细
|
| Treosulfan |
曲奥舒凡 |
299-75-2 |
详细
|
| AZ 10606120 dihydrochloride |
N-[2-[[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]-5-QUINOLINYL]-2-TRICYCLO[3.3.1.13,7]DEC-1-YLACETAMIDE DIHYDROCHLORIDE |
607378-18-7 |
详细
|
| PEO-IAA |
2-(1H-吲哚-3-基)-4-氧基-4-苯基亮氨酸 |
6266-66-6 |
详细
|
| AEM1 |
AEM1 |
1030123-90-0 |
详细
|
| ARN272 |
ARN272 |
488793-85-7 |
详细
|
| GSK2200150A |
1443138-53-1 |
1443138-53-1 |
详细
|
| TVB-3166 |
TVB-3166 |
1533438-83-3 |
详细
|
| BAY-293 |
(R)-6,7-二甲氧基-2-甲基-N-(1-(4-(2-((甲基氨基)甲基)苯基)噻吩-2-基)乙基)喹唑啉-4-胺 |
2244904-70-7 |
详细
|
| TH 5487 |
TH 5487 |
2304947-71-3 |
详细
|
| SKF38393 HCL |
SKF38393 HCL |
62717-42-4 |
详细
|
| PIM1/AKK1-IN-1 |
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺 |
1093222-27-5 |
详细
|
| GLPG0634 analogue |
GLPG0634 |
1206101-20-3 |
详细
|
| BAR501 |
CPDD0945 |
1632118-69-4 |
详细
|
| T 5601640 |
T5601640 |
924473-59-6 |
详细
|
| imidazenil |
米达西尼 |
151271-08-8 |
详细
|
| Ciforadenant (CPI-444) |
CPI-444 |
1202402-40-1 |
详细
|
| LY2795050 |
LY2795050 |
1346133-08-1 |
详细
|
| GSK2981278 |
GSK2981278 |
1474110-21-8 |
详细
|
| Elafibranor |
GFT505 |
923978-27-2 |
详细
|
| TM5007 |
化合物TM5007 |
342595-05-5 |
详细
|
| JNJ-63533054 |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺 |
1802326-66-4 |
详细
|
| FF-10101 |
FF-10101 |
1472797-69-5 |
详细
|
| Eliprodil |
依利罗地 |
119431-25-3 |
详细
|
| TSPC |
TSPC |
882286-32-0 |
详细
|
| MS4078 |
MS4078 |
2229036-62-6 |
详细
|
| JTE-013 |
JTE-013 |
383150-41-2 |
详细
|
| TAK-632 |
TAK-632 |
1228591-30-7 |
详细
|
| AZD-5069 |
AZD5069 |
878385-84-3 |
详细
|
| Seltorexant |
JNJ-42847922 |
1293281-49-8 |
详细
|
| 8-Bromo-cAMP sodium salt |
8-溴腺苷-3',5'-环单磷酸钠 |
76939-46-3 |
详细
|
| (-)-Dizocilpine |
(-)-MK801MALEATE |
121917-57-5 |
详细
|
| NCGC 607 |
NCGC607 |
1462267-07-7 |
详细
|
| R243 |
R243 |
688352-84-3 |
详细
|
| SKLB-23bb |
SKLB-23bb |
1815580-06-3 |
详细
|
| GATA4-NKX2-5-IN-1 |
化合物GATA4-NKX2-5-IN-1 |
544681-96-1 |
详细
|
| Fmoc-3VVD-OH |
FMOC-3AA-OH |
863971-44-2 |
详细
|
| PD-089828 |
PD089828 |
179343-17-0 |
详细
|
| AZD2098 |
AZD2098 |
566203-88-1 |
详细
|
| GSK-114 |
GSK-114 |
1301761-96-5 |
详细
|
| Mc-Val-Ala-PAB |
Mc-Val-Ala-PAB |
1870916-87-2 |
详细
|
| NDI-091143 |
NDI-091143 |
2375840-87-0 |
详细
|
| ML397 |
4-[3-[2-[[4-(乙酰氨基)苯基]硫代]乙酰]-2,5-二甲基-1H-吡咯-1-基]苯甲酸甲酯 |
731006-86-3 |
详细
|
| VU6015929 |
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]- |
2442597-56-8 |
详细
|
| GW9508 |
885101-89-3(GW9508) |
885101-89-3 |
详细
|
| Cinacalcethydrochloride |
盐酸甲状旁腺激素 |
364782-34-3 |
详细
|
| Maraviroc |
马拉维若 |
376348-65-1 |
详细
|
| AMD-070 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 |
558447-26-0 |
详细
|
| BQ-123 SODIUM SALT |
环(D-ALPHA-天冬氨酰-L-脯氨酰-D-缬氨酰-L-亮氨酰-D-色氨酰) |
136553-81-6 |
详细
|
| TAK-779 |
TAK 799 ;TAK 779 |
229005-80-5 |
详细
|
| GANT 61 |
2,2'-[[二氢-2-(4-吡啶基)-1,3(2H,4H)-嘧啶二基]二(亚甲基)]二[N,N-二甲基苯胺] |
500579-04-4 |
详细
|
| Vortioxetine(LuAA21004)HBr |
氢溴酸沃替西汀 |
960203-27-4 |
详细
|
| BNC105 |
BNC105 |
945771-74-4 |
详细
|
| Fmoc-Phe-Lys(Trt)-PAB-PNP |
FMOC-PHE-LYS(TRT)-PAB-PNP |
1116086-09-9 |
详细
|
| Voxelotor (GBT440) |
沃塞洛托 |
1446321-46-5 |
详细
|
| ARN14974 |
ARN14974 |
1644158-57-5 |
详细
|
| 5WKS |
化合物5WKS |
1350752-07-6 |
详细
|
| CYM2503 |
(9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氢喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 环己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 |
1308833-36-4 |
详细
|
| PZ-2891 |
PZ-2891 |
2170608-82-7 |
详细
|
| JNJ-7777120 |
JNJ7777120 |
459168-41-3 |
详细
|
| ML417 |
ML417 |
1386162-69-1 |
详细
|
| Simetride |
西美曲特 |
154-82-5 |
详细
|
| Conivaptan hydrochloride |
盐酸考尼伐坦 |
168626-94-6 |
详细
|
| OC000459 |
[5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸 |
851723-84-7 |
详细
|
| BAY 57-1293 |
普瑞利韦 |
348086-71-5 |
详细
|
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
详细
|
| PF-3450074 |
PF-3450074 |
1352879-65-2 |
详细
|
| Matrine |
苦参碱 |
519-02-8 |
详细
|
| GSK2256098 |
GSK-2256098 |
1224887-10-8 |
详细
|
| LOUREIRIN B |
龙血素B |
119425-90-0 |
详细
|
| FDL-169 |
FDL169 |
1628416-28-3 |
详细
|
| BAY 59-3074 |
BAY 59-3074 |
406205-74-1 |
详细
|
| Maytansine |
美坦新 |
35846-53-8 |
详细
|
| VUF 10166 |
VUF 10166 |
155584-74-0 |
详细
|
| TAE-1 |
2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide |
1414469-59-2 |
详细
|
| LY2828360 |
CS-2878 |
1231220-79-3 |
详细
|
| MCHR1 antagonist 2 |
863115-70-2 |
863115-70-2 |
详细
|
| UBCS039 |
UBCS039 |
358721-70-7 |
详细
|
| TH-257 |
TH-257 |
2244678-29-1 |
详细
|
| WUN-29654 |
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- |
2407829-65-4 |
详细
|